Reduction of Elevated Cytokine Levels in Acute/Acute-on-Chronic Liver Failure Using Super-Large Pore Albumin Dialysis Treatment: An In Vitro Study

Therapeutic Apheresis and Dialysis

Volumn 18, Issue 4, 2014, Pages 347-352

  Dominik, Adrian ^a   Stange, Jan ^a   Pfensig, Claudia ^a   Borufka, Luise ^a   Weiss Reining, Helga ^a   Eggert, Martin ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Albumin dialysis; Cytokine removal; Extracorporeal liver support; Molecular Adsorbents Recirculating System; Super large pore membrane

Indexed keywords

ALBUMIN; AMMONIA; BILIRUBIN; CREATININE; CYTOKINE; INTERLEUKIN 6; TOXIN; TUMOR NECROSIS FACTOR ALPHA; UREA; ALBUMINOID; ARTIFICIAL MEMBRANE;

ACUTE ON CHRONIC LIVER FAILURE; ALBUMIN DIALYSIS; ARTICLE; COMPARTMENT MODEL; CONTINUOUS INFUSION; DETOXIFICATION; DIALYSIS EQUIPMENT AND SUPPLIES; DIALYSIS MEMBRANE; IN VITRO STUDY; LIVER SUPPORT; MONITOR; PRIORITY JOURNAL; ACUTE-ON-CHRONIC LIVER FAILURE; ARTIFICIAL MEMBRANE; COMPARATIVE STUDY; EXTRACORPOREAL CIRCULATION; HUMAN; LIVER FAILURE, ACUTE; METABOLISM; PROCEDURES; RENAL REPLACEMENT THERAPY;

ACUTE-ON-CHRONIC LIVER FAILURE; ALBUMINS; CYTOKINES; EXTRACORPOREAL CIRCULATION; HUMANS; IN VITRO TECHNIQUES; LIVER FAILURE, ACUTE; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS;

EID: 84905907162     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12146     Document Type: Article

References (21)

1. Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008;49:845-861.
2. Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002;20:252-261.
3. Nevens F, Laleman W. Artificial liver support devices as treatment option for liver failure. Best Pract Res Clin Gastroenterol 2012;26:17-26.
4. Mitzner SR. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS). Ann Hepatol 2011;10(Suppl 1):S21-28.
5. Koivusalo A-M, Vakkuri A, Höckerstedt K, Isoniemi H. Experience of Mars therapy with and without transplantation in 101 patients with liver insufficiency. Transplant Proc 2005;37:3315-3317.
6. Isoniemi H, Koivusalo A-M, Repo H, Ilonen I, Höckerstedt K. The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation. Transplant Proc 2005;37:1088-1090.
7. Stadlbauer V, Krisper P, Aigner R etal. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 2006;10:R169.
8. Sen S, Davies NA, Mookerjee RP etal. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004;10:1109-1119.
9. Laleman W, Wilmer A, Evenepoel P, Verslype C, Fevery J, Nevens F. Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther 2006;23:351-363.
10. US Patent US20120305486-High cut-off hemodialysis membrane for use in liver dialysis. Available at: https://www.google.com/patents/US20120305486. Accessed 7 Mar 2013.
11. Caiazzo M, Monari E, Cuoghi A etal. Steps study: superhighflux therapies for hemodialysis. A proteomic approach. Available at: http://ndt.oxfordjournals.org/content/27/suppl_2/ii197.full. Accessed 7 Mar 2013.
12. CRRT Filter |, Fresenius Medical Care. Available at: http://www.fmc-deutschland.com/cps/rde/xchg/fme-germany_de/hs.xsl/2557.htm#. Accessed 7 Mar 2013.
13. Morgera S, Slowinski T, Melzer C etal. Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 2004;43:444-453.
14. Hoffmann A, Müller MQ, Gloser M, Sinz A, Rudolph R, Pfeifer S. Recombinant production of bioactive human TNF-alpha by SUMO-fusion system-high yields from shake-flask culture. Protein Expr Purif 2010;72:238-243.
15. Marušič J, Podlipnik Č, Jevševar S, Kuzman D, Vesnaver G, Lah J. Recognition of human tumor necrosis factor α (TNF-α) by therapeutic antibody fragment: energetics and structural features. J Biol Chem 2012;287:8613-8620.
16. Hagiwara S, Iwasaka H, Hasegawa A etal. Continuous hemodiafiltration therapy ameliorates LPS-induced systemic inflammation in a rat model. J Surg Res 2011;171:791-796.
17. Hecht N, Pappo O, Shouval D, Rose-John S, Galun E, Axelrod JH. Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Mol Ther 2001;3(5 Pt 1):683-687.
18. Ilonen I, Koivusalo A-M, Repo H, Höckerstedt K, Isoniemi H. Cytokine profiles in acute liver failure treated with albumin dialysis. Artif Organs 2008;32:52-60.
19. Mullin EJ, Metcalfe MS, Maddern GJ. Artificial liver support: potential to retard regeneration? Arch Surg 2004;139:670-677.
20. Liu Q. Role of cytokines in the pathophysiology of acute-on-chronic liver failure. Blood Purif 2009;28:331-341.
21. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-867.